Benjamin Solomon

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 3

Top Topics

Advanced Non Small Cell Lung Cancer

Epidermal Growth Factor Receptor

Top Venues

JCO precision oncology

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Alexander E Drilon, Daniel Shao-Weng Tan, Ulrik N Lassen, Serge Leyvraz, Yongmei Liu, Jyoti D Patel, Lee S Rosen, Benjamin Solomon, Ricarda Norenberg, Laura Dima, Nicoletta Brega, Lin Shen, Victor Moreno, Shivaani Kummar, Jessica J Lin
Efficacy and Safety of Larotrectinib in Patients With Tropomyosin Receptor Kinase Fusion-Positive Lung Cancers. JCO precision oncology 6 (2022)
Benjamin Solomon, Ana Callejo, Jair Bar, Guy Berchem, Lyudmila Bazhenova, Pierre Saintigny, Fanny Wunder, Jacques Raynaud, Nicolas Girard, J Jack Lee, Raed Sulaiman, Bruce Prouse, Catherine Bresson, Hila Ventura, Shai Magidi, Eitan Rubin, Brandon Young, Amir Onn, Brian Leyland-Jones, Richard L Schilsky, Vladimir Lazar, Enriqueta Felip, Razelle Kurzrock
A WIN Consortium phase I study exploring avelumab, palbociclib, and axitinib in advanced non-small cell lung cancer. Cancer medicine 11 (14) (2022)
Vladimir Lazar, Nicolas Girard, Eric Raymond, Jean-Francois Martini, Susan Galbraith, Jacques Raynaud, Catherine Bresson, Benjamin Solomon, Shai Magidi, Hovav Nechushtan, Amir Onn, Raanan Berger, Haiquan Chen, Amal Al-Omari, Sadakatsu Ikeda, Ulrik N Lassen, Marina Sekacheva, Enriqueta Felip Font, Josep Tabernero, Gerald Batist, Alan Spatz, Conjeevaram S Pramesh, Philippe Girard, Jean Yves Blay, Thierry Philip, Ioana Berindan Neagoe, Angel Porgador, Eitan Rubin, Razelle Kurzrock, Richard L Schilsky
Transcriptomics in Tumor and Normal Lung Tissues Identify Patients With Early-Stage Non-Small-Cell Lung Cancer With High Risk of Postsurgery Recurrence Who May Benefit From Adjuvant Therapies. JCO precision oncology 6 (2022)